Structural biology of plasmodial proteins

Current Opinion in Structural Biology

Volumn 17, Issue 6, 2007, Pages 744-754

  Gayathri, P ^a   Balaram, Hemalatha ^b   Murthy, MRN ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

2,6 DIHYDROXY NAPHTHALENE DERIVATIVE; 4,6 DIAMINO 1,2 DIHYDRO 2,2 DIMETHYL 1 [3 (2,4,5 TRICHLOROPHENOXY)PROPOXY] 1,3,5 TRIAZINE; 5 METHYLTHIO IMMUCILLIN H; 7 P TRIFLUOROMETHYLBENZYL 8 DEOXYHEMIGOSSYLIC ACID; 8 AZAGUANINE; ACIVICIN; ACTINONIN; AMINOQUINOLINE DERIVATIVE; BENZAMIDE DERIVATIVE; BREQUINAR; CHALCONE DERIVATIVE; CONGO RED; CYCLOGUANIL; CYCLOSPORIN A; GOSSYPOL DERIVATIVE; HEMATIN; HEXACHLOROPHENE; IMMUCILLIN GP; IMMUCILLIN HP; IMMUNOSUPPRESSIVE AGENT; MALARIA VACCINE; MEMBRANE PROTEIN; METESIND GLUCURONATE; N (3,5 DICHLORO PHENYL) 2 METHYL 3 NITRO BENZAMIDE; NAPHTHALENE DERIVATIVE; NEROLIDOL; PYRIMETHAMINE; SEMICARBAZONE DERIVATIVE; TRICLOSAN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

DETOXIFICATION; DRUG MECHANISM; ENZYME METABOLISM; HOST PARASITE INTERACTION; HUMAN; MALARIA; MORTALITY; NONHUMAN; PARASITE CONTROL; PLASMODIUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN STRUCTURE; REVIEW;

ANIMALS; MODELS, MOLECULAR; PLASMODIUM; PROTEIN CONFORMATION; PROTOZOAN PROTEINS;

EID: 36549047534     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sbi.2007.08.001     Document Type: Review

References (82)

1. Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G., Smith H.O., Yandell M., Evans C.A., Holt R.A., et al. The sequence of the human genome. Science 291 (2001) 1304-1351
2. Gardner M.J., Hall N., Fung E., White O., Berriman M., Hyman R.W., Carlton J.M., Pain A., Nelson K.E., Bowman S., et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419 (2002) 498-511
3. Holt R.A., Subramanian G.M., Halpern A., Sutton G.G., Charlab R., Nusskern D.R., Wincker P., Clark A.G., Ribeiro J.M., Wides R., et al. The genome sequence of the malaria mosquito Anopheles gambiae. Science 298 (2002) 129-149
4. Florens L., Washburn M.P., Raine J.D., Anthony R.M., Grainger M., Haynes J.D., Moch J.K., Muster N., Sacci J.B., Tabb D.L., et al. A proteomic view of the Plasmodium falciparum life cycle. Nature 419 (2002) 520-526
5. Mehlin C. Structure-based drug discovery for Plasmodium falciparum. Comb Chem High Throughput Screen 8 (2005) 5-14. The review summarizes the structure-based drug discovery efforts against the malarial parasite till 2005.
6. Vedadi M., Lew J., Artz J., Amani M., Zhao Y., Dong A., Wasney G.A., Gao M., Hills T., Brokx S., et al. Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms. Mol Biochem Parasitol 151 (2007) 100-110. The authors give a detailed account on the expression and crystallizability of plasmodial proteins and report the plasmodial structures solved by the structural genomics consortium (SGC).
7. Pizarro J.C., Chitarra V., Verger D., Holm I., Petres S., Dartevelle S., Nato F., Longacre S., and Bentley G.A. Crystal structure of a Fab complex formed with PfMSP1-19, the C-terminal fragment of merozoite surface protein 1 from Plasmodium falciparum: a malaria vaccine candidate. J Mol Biol 328 (2003) 1091-1103
8. Feng Z.P., Keizer D.W., Stevenson R.A., Yao S., Babon J.J., Murphy V.J., Anders R.F., and Norton R.S. Structure and inter-domain interactions of domain II from the blood-stage malarial protein, apical membrane antigen 1. J Mol Biol 350 (2005) 641-656
9. Singh S.K., Hora R., Belrhali H., Chitnis C.E., and Sharma A. Structural basis for Duffy recognition by the malaria parasite Duffy-binding-like domain. Nature 439 (2006) 741-744. The features of the DARC-binding site and strategies for inhibiting the invasion of the parasite on the basis of the interaction between DBL and DARC are discussed.
10. Tolia N.H., Enemark E.J., Sim B.K., and Joshua-Tor L. Structural basis for the EBA-175 erythrocyte invasion pathway of the malaria parasite Plasmodium falciparum. Cell 122 (2005) 183-193
11. Saxena A.K., Singh K., Su H.P., Klein M.M., Stowers A.W., Saul A.J., Long C.A., and Garboczi D.N. The essential mosquito-stage P25 and P28 proteins from Plasmodium form tile-like triangular prisms. Nat Struct Mol Biol 13 (2006) 90-91. The structural features of P25 and P28 that are potential candidates for transmission blocking vaccines are described.
12. Bentley G.A. Functional and immunological insights from the three-dimensional structures of Plasmodium surface proteins. Curr Opin Microbiol 9 (2006) 395-400. The review covers the reports on structural studies of malarial surface proteins that are potential vaccine candidates.
13. Howell D.P., Samudrala R., and Smith J.D. Disguising itself-insights into Plasmodium falciparum binding and immune evasion from the DBL crystal structure. Mol Biochem Parasitol 148 (2006) 1-9
14. McHenry A.M., and Adams J.H. The crystal structure of P. knowlesi DBP-α DBL domain and its implications for immune evasion. Trends Biochem Sci 31 (2006) 487-491
15. 19 and discusses events connected with proteolytic processing of the MSP-I complex during various stages of the parasite life cycle.
16. Serrano M.L., Perez H.A., and Medina J.D. Structure of C-terminal fragment of merozoite surface protein-1 from Plasmodium vivax determined by homology modeling and molecular dynamics refinement. Bioorg Med Chem 14 (2006) 8359-8365
17. James S., Moehle K., Renard A., Mueller M.S., Vogel D., Zurbriggen R., Pluschke G., and Robinson J.A. Synthesis, solution structure and immune recognition of an epidermal growth factor-like domain from Plasmodium falciparum merozoite surface protein-1. Chembiochem 7 (2006) 1943-1950. This work shows that a chemically synthesized domain of MSP-I adopts a native-like structure, and studies using virosomes can be used for optimization of the antigenicity of the protein.
18. Low A., Chandrashekaran I.R., Adda C.G., Yao S., Sabo J.K., Zhang X., Soetopo A., Anders R.F., and Norton R.S. Merozoite surface protein 2 (MSP2) of Plasmodium falciparum: expression, structure, dynamics and fibril formation of the conserved N-terminal domain. Biopolymers 87 (2007) 12-22
19. Igonet S., Vulliez-Le Normand B., Faure G., Riottot M.M., Kocken C.H., Thomas A.W., and Bentley G.A. Cross-reactivity studies of an anti-Plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterisation. J Mol Biol 366 (2007) 1523-1537. The paper reports the structure of PfAMA-I complexed with F8.12.19 and provides an explanation for the structural basis of cross reactivity.
20. Bosch J., Turley S., Daly T.M., Bogh S.M., Villasmil M.L., Roach C., Zhou N., Morrisey J.M., Vaidya A.B., Bergman L.W., et al. Structure of the MTIP-MyoA complex, a key component of the malaria parasite invasion motor. Proc Natl Acad Sci USA 103 (2006) 4852-4857. The crystal structure of MTIP-MyoA complex captures three different conformations of the C-terminal domain and describes the binding of MyoA tail.
21. Bosch J., Buscaglia C.A., Krumm B., Ingason B.P., Lucas R., Roach C., Cardozo T., Nussenzweig V., and Hol W.G. Aldolase provides an unusual binding site for thrombospondin-related anonymous protein in the invasion machinery of the malaria parasite. Proc Natl Acad Sci USA 104 (2007) 7015-7020. The structure report describes the induced fit mode of binding of a fragment of TRAP-tail to aldolase and the significance of the multimeric status of aldolase for its non-enzymatic role in the invasion machinery.
22. Tossavainen H., Pihlajamaa T., Huttunen T.K., Raulo E., Rauvala H., Permi P., and Kilpelainen I. The layered fold of the TSR domain of P. falciparum TRAP contains a heparin binding site. Protein Sci 15 (2006) 1760-1768. The solution NMR structure of the TSR domain of TRAP and its heparin-binding properties that facilitate cell recognition are described.
23. Wang S.X., Pandey K.C., Somoza J.R., Sijwali P.S., Kortemme T., Brinen L.S., Fletterick R.J., Rosenthal P.J., and McKerrow J.H. Structural basis for unique mechanisms of folding and hemoglobin binding by a malarial protease. Proc Natl Acad Sci USA 103 (2006) 11503-11508. The novel structural features of falcipain-2 and their role in folding and binding of haemoglobin are described.
24. Hogg T., Nagarajan K., Herzberg S., Chen L., Shen X., Jiang H., Wecke M., Blohmke C., Hilgenfeld R., and Schmidt C.L. Structural and functional characterization of falcipain-2, a hemoglobinase from the malarial parasite Plasmodium falciparum. J Biol Chem 281 (2006) 25425-25437. The biochemical characterization of falcipain-2 with respect to its pH dependence of activity and binding to haemoglobin are correlated with the crystal structure.
25. Ersmark K., Nervall M., Gutierrez-de-Teran H., Hamelink E., Janka L.K., Clemente J.C., Dunn B.M., Gogoll A., Samuelsson B., Qvist J., et al. Macrocyclic inhibitors of the malarial aspartic proteases plasmepsin I, II, and IV. Bioorg Med Chem 14 (2006) 2197-2208
26. Gutierrez-de-Teran H., Nervall M., Ersmark K., Liu P., Janka L.K., Dunn B., Hallberg A., and Aqvist J. Inhibitor binding to the plasmepsin IV aspartic protease from Plasmodium falciparum. Biochemistry 45 (2006) 10529-10541
27. Johansson P.O., Lindberg J., Blackman M.J., Kvarnstrom I., Vrang L., Hamelink E., Hallberg A., Rosenquist A., and Samuelsson B. Design and synthesis of potent inhibitors of plasmepsin I and II: X-ray crystal structure of inhibitor in complex with plasmepsin II. J Med Chem 48 (2005) 4400-4409
28. Clemente J.C., Govindasamy L., Madabushi A., Fisher S.Z., Moose R.E., Yowell C.A., Hidaka K., Kimura T., Hayashi Y., Kiso Y., et al. Structure of the aspartic protease plasmepsin IV from the malarial parasite Plasmodium malariae bound to an allophenylnorstatine-based inhibitor. Acta Crystallogr D Biol Crystallogr 62 (2006) 246-252
29. Boucher I.W., Brzozowski A.M., Brannigan J.A., Schnick C., Smith D.J., Kyes S.A., and Wilkinson A.J. The crystal structure of superoxide dismutase from Plasmodium falciparum. BMC Struct Biol 6 (2006) 20. This report of the crystal structure explores the differences between human and Plasmodium superoxide dismutases.
30. Boucher I.W., McMillan P.J., Gabrielsen M., Akerman S.E., Brannigan J.A., Schnick C., Brzozowski A.M., Wilkinson A.J., and Muller S. Structural and biochemical characterization of a mitochondrial peroxiredoxin from Plasmodium falciparum. Mol Microbiol 61 (2006) 948-959
31. Hiller N., Fritz-Wolf K., Deponte M., Wende W., Zimmermann H., and Becker K. Plasmodium falciparum glutathione S-transferase-structural and mechanistic studies on ligand binding and enzyme inhibition. Protein Sci 15 (2006) 281-289
32. Robien M.A., Bosch J., Buckner F.S., Van Voorhis W.C., Worthey E.A., Myler P., Mehlin C., Boni E.E., Kalyuzhniy O., Anderson L., et al. Crystal structure of glyceraldehyde-3-phosphate dehydrogenase from Plasmodium falciparum at 2.25 A resolution reveals intriguing extra electron density in the active site. Proteins 62 (2006) 570-577
33. Caruthers J., Bosch J., Buckner F., Van Voorhis W., Myler P., Worthey E., Mehlin C., Boni E., DeTitta G., Luft J., et al. Structure of a ribulose 5-phosphate 3-epimerase from Plasmodium falciparum. Proteins 62 (2006) 338-342
34. Holmes M.A., Buckner F.S., Van Voorhis W.C., Verlinde C.L., Mehlin C., Boni E., DeTitta G., Luft J., Lauricella A., Anderson L., et al. Structure of ribose 5-phosphate isomerase from Plasmodium falciparum. Acta Crystallogr Sect F Struct Biol Cryst Commun 62 (2006) 427-431
35. Hurt D.E., Widom J., and Clardy J. Structure of Plasmodium falciparum dihydroorotate dehydrogenase with a bound inhibitor. Acta Crystallogr D Biol Crystallogr 62 (2006) 312-323. The differences in the inhibition of the enzyme from various species are correlated with the differences in the structure of the quinone-binding tunnel.
36. Gengenbacher M., Fitzpatrick T.B., Raschle T., Flicker K., Sinning I., Muller S., Macheroux P., Tews I., and Kappes B. Vitamin B6 biosynthesis by the malaria parasite Plasmodium falciparum: biochemical and structural insights. J Biol Chem 281 (2006) 3633-3641. The authors report the crystal structure of the Pdx2 domain and biochemical characterization of the complex formation of Pdx1 and Pdx2 domains involved in vitamin B6 biosynthesis.
37. Burger P.B., Birkholtz L.M., Joubert F., Haider N., Walter R.D., and Louw A.I. Structural and mechanistic insights into the action of Plasmodium falciparum spermidine synthase. Bioorg Med Chem 15 (2007) 1628-1637
38. Wickramasinghe S.R., Inglis K.A., Urch J.E., Muller S., van Aalten D.M., and Fairlamb A.H. Kinetic, inhibition and structural studies on 3-oxoacyl-ACP reductase from Plasmodium falciparum, a key enzyme in fatty acid biosynthesis. Biochem J 393 (2006) 447-457. The crystal structure and the kinetics of inhibition of the enzyme are described.
39. Sharma A.K., Sharma S.K., Surolia A., Surolia N., and Sarma S.P. Solution structures of conformationally equilibrium forms of holo-acyl carrier protein (PfACP) from Plasmodium falciparum provides insight into the mechanism of activation of ACPs. Biochemistry 45 (2006) 6904-6916. The NMR structure of PfACP is reported along with a comparison with ACPs from other organisms.
40. Swarnamukhi P.L., Sharma S.K., Bajaj P., Surolia N., Surolia A., and Suguna K. Crystal structure of dimeric FabZ of Plasmodium falciparum reveals conformational switching to active hexamers by peptide flips. FEBS Lett 580 (2006) 2653-2660
41. Kostrewa D., Winkler F.K., Folkers G., Scapozza L., and Perozzo R. The crystal structure of PfFabZ, the unique β-hydroxyacyl-ACP dehydratase involved in fatty acid biosynthesis of Plasmodium falciparum. Protein Sci 14 (2005) 1570-1580
42. Muench S.P., Prigge S.T., McLeod R., Rafferty J.B., Kirisits M.J., Roberts C.W., Mui E.J., and Rice D.W. Studies of Toxoplasma gondii and Plasmodium falciparum enoyl acyl carrier protein reductase and implications for the development of antiparasitic agents. Acta Crystallogr D Biol Crystallogr 63 (2007) 328-338
43. +-dependent dimerization and inactivation: functional and crystallographic analysis. J Mol Biol 367 (2007) 501-513
44. Holmes M.A., Buckner F.S., Van Voorhis W.C., Mehlin C., Boni E., Earnest T.N., DeTitta G., Luft J., Lauricella A., Anderson L., et al. Structure of the conserved hypothetical protein MAL13P1.257 from Plasmodium falciparum. Acta Crystallogr Sect F Struct Biol Cryst Commun 62 (2006) 180-185
45. DeLano W.L. The PYMOL Molecular Graphics System (2002), DeLano Scientific, San Carlos, CA
46. Joubert F., Neitz A.W., and Louw A.I. Structure-based inhibitor screening: a family of sulfonated dye inhibitors for malaria parasite triosephosphate isomerase. Proteins 45 (2001) 136-143
47. Velanker S.S., Ray S.S., Gokhale R.S., Suma S., Balaram H., Balaram P., and Murthy M.R.N. Triosephosphate isomerase from Plasmodium falciparum: the crystal structure provides insights into antimalarial drug design. Structure 5 (1997) 751-761
48. Gomez M.S., Piper R.C., Hunsaker L.A., Royer R.E., Deck L.M., Makler M.T., and Vander Jagt D.L. Substrate and cofactor specificity and selective inhibition of lactate dehydrogenase from the malarial parasite P. falciparum. Mol Biochem Parasitol 90 (1997) 235-246
49. Chaikuad A., Fairweather V., Conners R., Joseph-Horne T., Turgut-Balik D., and Brady R.L. Structure of lactate dehydrogenase from Plasmodium vivax: complexes with NADH and APADH. Biochemistry 44 (2005) 16221-16228
50. Campanale N., Nickel C., Daubenberger C.A., Wehlan D.A., Gorman J.J., Klonis N., Becker K., and Tilley L. Identification and characterization of heme-interacting proteins in the malaria parasite, Plasmodium falciparum. J Biol Chem 278 (2003) 27354-27361
51. Dax C., Duffieux F., Chabot N., Coincon M., Sygusch J., Michels P.A.M., and Blonski C. Selective irreversible inhibition of fructose 1,6-bisphosphate aldolase from Trypanosoma brucei. J Med Chem 49 (2006) 1499-1502
52. Boa A.N., Canavan S.P., Hirst P.R., Ramsey C., Stead A.M.W., and McConkey G.A. Synthesis of brequinar analogue inhibitors of malaria parasite dihydroorotate dehydrogenase. Bioorg Med Chem 13 (2005) 1945-1967
53. Baldwin J., Michnoff C.H., Malmquist N.A., White J., Roth M.G., Rathod P.K., and Phillips M.A. High-throughput screening for potent and selective inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase. J Biol Chem 280 (2005) 21847-21853
54. Kamchonwongpaisan S., Vanichtanankul J., Taweechai S., Chitnumsub P., and Yuthavong Y. The role of tryptophan-48 in catalysis and binding of inhibitors of Plasmodium falciparum dihydrofolate reductase. Int J Parasitol 37 (2007) 787-793
55. Hastings M.D., and Sibley C.H. Pyrimethamine and WR99210 exert opposing selection on dihydrofolate reductase from Plasmodium vivax. Proc Natl Acad Sci USA 99 (2002) 13137-13141
56. Yuvaniyama J., Chitnumsub P., Kamchonwongpaisan S., Vanichtanankul J., Sirawaraporn W., Taylor P., Walkinshaw M.D., and Yuthavong Y. Insights into antifolate resistance from malarial DHFR-TS structures. Nat Struct Mol Biol 10 (2003) 357-365
57. Pang C.K.T., De S.K., White J., Buckner F.S., Varani G., and Rathod P.K. Differential drug binding by the highly conserved Plasmodium falciparum thymidylate synthase. Mol Biochem Parasitol 143 (2005) 121-124
58. Li C.M., Tyler P.C., Furneaux R.H., Kicska G., Xu Y., Grubmeyer C., Girvin M.E., and Schramm V.L. Transition-state analogs as inhibitors of human and malarial hypoxanthine-guanine phosphoribosyltransferases. Nat Struct Mol Biol 6 (1999) 582-587
59. Shi W., Li C.M., Tyler P.C., Furneaux R.H., Cahill S.M., Girvin M.E., Grubmeyer C., Schramm V.L., and Almo S.C. The 2.0 A structure of malarial purine phosphoribosyltransferase in complex with a transition-state analogue inhibitor. Biochemistry 38 (1999) 9872-9880
60. Keough D.T., Skinner-Adams T., Jones M.K., Ng A.L., Brereton I.M., Guddat L.W., and deJersey J. Lead compounds for antimalarial chemotherapy: purine base analogs discriminate between human and P. falciparum 6-oxopurine phosphoribosyltransferases. J Med Chem 49 (2006) 7479-7486
61. Shi W., Ting L.-M., Kicska G.A., Lewandowicz A., Tyler P.C., Evans G.B., Furneaux R.H., Kim K., Almo S.C., and Schramm V.L. Plasmodium falciparum purine nucleoside phosphorylase: crystal structures, immucillin inhibitors, and dual catalytic function. J Biol Chem 279 (2004) 18103-18106
62. Raman J., Mehrotra S., Anand R.P., and Balaram H. Unique kinetic mechanism of Plasmodium falciparum adenylosuccinate synthetase. Mol Biochem Parasitol 138 (2004) 1-8
63. Eaazhisai K., Jayalakshmi R., Gayathri P., Anand R.P., Sumathy K., Balaram H., and Murthy M.R. Crystal structure of fully ligated adenylosuccinate synthetase from Plasmodium falciparum. J Mol Biol 335 (2004) 1251-1264
64. Krungkrai S.R., DelFraino B.J., Smiley J.A., Prapunwattana P., Mitamura T., Horii T., and Krungkrai J. A novel enzyme complex of orotate phosphoribosyltransferase and orotidine 5′-monophosphate decarboxylase in human malaria parasite Plasmodium falciparum: physical association, kinetics, and inhibition characterization. Biochemistry 44 (2005) 1643-1652
65. Bracchi-Ricard V., Nguyen K.T., Zhou Y., Rajagopalan P.T.R., Chakrabarti D., and Pei D. Characterization of a eukaryotic peptide deformylase from Plasmodium falciparum. Arch Biochem Biophys 396 (2001) 162-170
66. Kumar A., Nguyen K.T., Srivathsan S., Ornstein B., Turley S., Hirsh I., Pei D., and Hol W.G.J. Crystals of peptide deformylase from Plasmodium falciparum reveal critical characteristics of the active site for drug design. Structure 10 (2002) 357-367
67. Tonhosolo R., D'Alexandri F.L., Genta F.A., Wunderlich G., Gozzo F.C., Eberlin M.N., Peres V.J., Kimura E.A., and Katzin A.M. Identification, molecular cloning and functional characterization of an octaprenyl pyrophosphate synthase in intra-erythrocytic stages of Plasmodium falciparum. Biochem J 392 (2005) 117-126
68. Kapoor M., Jamal Dar M., Surolia A., and Surolia N. Kinetic determinants of the interaction of enoyl-ACP reductase from Plasmodium falciparum with its substrates and inhibitors. Biochem Biophys Res Commun 289 (2001) 832-837
69. Surolia N., and Surolia A. Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum. Nat Med 7 (2001) 167-173
70. Perozzo R., Kuo M., Sidhu A.S., Valiyaveettil J.T., Bittman R., Jacobs Jr. W.R., Fidock D.A., and Sacchettini J.C. Structural elucidation of the specificity of the antibacterial agent triclosan for malarial enoyl acyl carrier protein reductase. J Biol Chem 277 (2002) 13106-13114
71. Freundlich J.S., Wang F., Tsai H.C., Kuo M., Shieh H.M., Anderson J.W., Nkrumah L.J., Valderramos J.C., Yu M., Kumar T.R., et al. X-ray structural analysis of Plasmodium falciparum enoyl acyl carrier protein reductase as a pathway towards the optimization of triclosan antimalarial efficacy. J Biol Chem 282 (2007) 25436-25444
72. Boss C., Corminboeuf O., Grisostomi C., Meyer S., Jones A.F., Prade L., Binkert C., Fischli W., Weller T., and Bur D. Achiral, cheap, and potent inhibitors of plasmepsins I, II, and IV. Chem Med Chem 1 (2006) 1341-1345
73. Chipeleme A., Gut J., Rosenthal P.J., and Chibale K. Synthesis and biological evaluation of phenolic Mannich bases of benzaldehyde and (thio)semicarbazone derivatives against the cysteine protease falcipain-2 and a chloroquine resistant strain of Plasmodium falciparum. Bioorg Med Chem 15 (2007) 273-282
74. Soulere L., Delplace P., Davioud-Charvet E., Py S., Sergheraert C., Perie J., Ricard I., Hoffmann P., and Dive D. Screening of Plasmodium falciparum iron superoxide dismutase inhibitors and accuracy of the SOD-assays. Bioorg Med Chem 11 (2003) 4941-4944
75. Liebau E., Bergmann B., Campbell A.M., Teesdale-Spittle P., Brophy P.M., Luersen K., and Walter R.D. The glutathione S-transferase from Plasmodium falciparum. Mol Biochem Parasitol 124 (2002) 85-90
76. Perbandt M., Burmeister C., Walter R.D., Betzel C., and Liebau E. Native and inhibited structure of a Mu class-related glutathione S-transferase from Plasmodium falciparum. J Biol Chem 279 (2004) 1336-1342
77. Fritz-Wolf K., Becker A., Rahlfs S., Harwaldt P., Schirmer R.H., Kabsch W., and Becker K. X-ray structure of glutathione S-transferase from the malarial parasite Plasmodium falciparum. Proc Natl Acad Sci USA 100 (2003) 13821-13826
78. Sarma G.N., Savvides S.N., Becker K., Schirmer M., Schirmer R.H., and Karplus P.A. Glutathione reductase of the malarial parasite Plasmodium falciparum: crystal structure and inhibitor development. J Mol Biol 328 (2003) 893-907
79. Bell A., Wernli B., and Franklin R.M. Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin. Biochem Pharmacol 48 (1994) 495-503
80. Peterson M.R., Hall D.R., Berriman M., Nunes J.A., Leonard G.A., Fairlamb A.H., and Hunter W.N. The three-dimensional structure of a Plasmodium falciparum cyclophilin in complex with the potent anti-malarial cyclosporin A. J Mol Biol 298 (2000) 123-133
81. Tanaka N., Nakanishi M., Kusakabe Y., Shiraiwa K., Yabe S., Ito Y., Kitade Y., and Nakamura K.T. Crystal structure of S-adenosyl-l-homocysteine hydrolase from the human malaria parasite Plasmodium falciparum. J Mol Biol 343 (2004) 1007-1017
82. Haider N., Eschbach M.L., Dias Sde S., Gilberger T.W., Walter R.D., and Luersen K. The spermidine synthase of the malaria parasite Plasmodium falciparum: molecular and biochemical characterisation of the polyamine synthesis enzyme. Mol Biochem Parasitol 142 (2005) 224-236